Pharmaxis
Presence
Boehringer Ingelheim is one of the...
Boehringer Ingelheim has 17 subsidiaries including Boehringer Ingelheim Animal Health USA, Boehringer Ingelheim Asia and Boehringer Ingelheim Belgium.
Executives
View the org chart displaying its 7 main executives
Most searched biographies at Pharmaxis
- Gary Phillips, Chief Executive Officer and Director
- Hashan De Silva, Non-Executive Director
- Kathleen Metters, Chairman of the Board
Create your alert
to follow the executive moves at Pharmaxis.
Pharmaceuticals
Boehringer Ingelheim has 1,869 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Pharmaxis
- Syntara Limited name registered by ASIC - Pharmaxis
- News - Pharmaxis
- Syntara Receives $5m R&D Tax Incentive - Pharmaxis
- News - Pharmaxis
- Syntara doses first patient in Phase 2 trial of patients with sleep disorder at risk of Parkinson’s disease - Pharmaxis
- News - Pharmaxis
- Pharmaxis Quarterly Shareholder Update and Investor Briefing - Pharmaxis
- News - Pharmaxis
- Notice of 2023 Annual General Meeting - Pharmaxis
- News - Pharmaxis
- View more press releases Close
Social media about Pharmaxis
- Pharmaxis on Wikipedia, Google News & Yahoo Finance
- Pharmaxis on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Gary Phillips 
